The researchers found that the primary composite reactogenicity outcome was noninferior in the simultaneous vs the sequential group. (HealthDay News) — Reactogenicity is comparable for simultaneous ...

People are losing their minds over Boots’ Christmas ad for being too woke...but it’s hardly the first campaign to receive a ...

A Northeastern University professor says public health experts are concerned that vaccine skeptic Robert F. Kennedy Jr. is setting the stage for confusion about childhood vaccination schedules—even ...

Novavax is already poised to benefit from a separate combined Covid-flu vaccine via a deal with Sanofi announed earlier this year. Under the $1.4 billion co-licensing agreement, announced in May, ...

Shares of the vaccine maker rose nearly 14% to $10.17 in premarket trading. Novavax had announced the clinical hold on the trial last month after a participant who had received its COVID-influenza ...

The U.S. Food and Drug Administration (FDA) has lifted its hold on a late-stage trial for Novavax’s COVID-influenza ...

India needs to expand its local vaccine manufacturing and research to give better control over safety of these pharma ...

Novavax (NVAX) shares surge 12% as FDA lifts clinical hold on COVID-19-Influenza Combination vaccine candidates.

With respiratory illness season underway, the New York State Department of Health is actively urging residents aged 6 months ...

By Ayako Wakatsuki Pedersen, Ph.D., Senior Vice President of Translational Research at IO Biotech | Making the tumor microenvironment hostile to cancer cells and immune-suppressive cells may transform ...

Welcome back to Health Brief, where your author spent much of the weekend chasing rumors about President-elect Donald Trump’s next Cabinet. If your name is on this prediction market’s list of betting ...